Bhadauria Pradeep 4
4 · Amneal Pharmaceuticals, Inc. · Filed Nov 14, 2019
Insider Transaction Report
Form 4
Bhadauria Pradeep
SVP, Chief Scientific Officer
Transactions
- Disposition to Issuer
Stock Option
2019-11-13−153,846→ 0 totalExercise: $13.28Exp: 2029-04-15→ Class A Common Stock (153,846 underlying) - Award
Stock Option
2019-11-13+153,846→ 153,846 totalExercise: $2.75Exp: 2029-04-15→ Class A Common Stock (153,846 underlying)
Footnotes (1)
- [F1]The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on April 15, 2019, and will vest in four equal annual installments beginning on April 15, 2020.